In response to the emails you have sent to many local associations of Québec solidaire, thank you for giving us the opportunity to know our guidance to your members health.
Your party he favors a funding model for health services focused on the patient rather than a funding model based on the establishment, and if so, why?
Québec solidaire is not conducive to a financing activity (FPA) or patient because:
- The FPA does not address the real causes of problems the hospital system.
- The gains in efficiency are uncertain. For cons, the administrative costs increase and the bureaucracy to manage, among other things, the phenomenon of gaming (or games with the data) and up-coding (upgrade certain activities).
- The FPA encourages « over-treatment » of certain low-risk populations to the detriment of patients at higher risk, less predictable, which are outsourced.
- The increase in day surgery can have negative consequences. It opens the door to private clinics in day surgery profit.
- FPA helps to create a market for hospital services, internal market and potentially in competition with the private sector.
Approval of drugs
HealthEdition.com said that in 2011, Quebec was the eighth of the ten provinces in Canada which was to cover new treatments against cancer. If elected, your government he committed to increasing the number of new drugs approved reimbursement for the care of cancer or other diseases, so that the entire Quebec population has timely access to medicines it needs, and if so, how will he accomplish?
Since its founding in 2006, QS proposes to review thoroughly all of the existing drug policy. To ensure the safety and accessibility of medicines quality while improving cost control for the population and for the State wishes to post QS drug policy interests of the industry.
The new public drug policy based on
- a rigorous evaluation of new drugs, fully public and independent, based on the best medical information;
- continuous training of practitioners (pharmacists, physicians and nurses) independent of pharmaceutical companies;
- sustained campaigns of prevention and public awareness to foster a more rational use of medicines.
and, inter alia because:
- Drug expenditure per person / year are $ 1,019 in Quebec, compared to $ 758 in British Columbia, a province where the costs are lowest (forecast 2013: $ 1,067 vs. $ 761) 3.
- Quebec spends a larger share of its budget on drugs than the rest of Canada: 19.5% vs 16.5%. But this is the last among Canadian provinces for total health expenditure per capita.
- Drug expenditures are also higher than in the OECD countries as a percentage of GDP, 27% higher in Canada than the average of 31 OECD countries. Among them, only the United States spends more per capita than Canada4. And Quebec spends more than Canada!
And contrary to the claims industry, Quebec reimburses twice more drugs than the Canadian average. The pharmaco-economic analysis is lax. More than 7,000 drugs are on the list of reimbursable drugs by the RAMQ vs New Zealand 2600.
In this campaign, Québec solidaire offers a comprehensive social vision for the love of a Quebec just for people with cancer and their loved ones, as for all those who live in Quebec.